4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-21-012960
Chief Executive Officer sold 18,990 shares at $14.83 ($281,644)
From the SEC's structured data for this filing
Trades in this filing
Kauffman Michael · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-18 | Sale : show line 1 in the form | −9,495 | $14.83 | $140,822 | 575,126 | D |
| 2021-02-18 | Sale : show line 2 in the form | −9,495 | $14.83 | $140,822 | 776,452 | I |
| Open-market sales · 18,990 sh · avg $14.83 · $281,644 | ||||||
Loading xslF345X03/doc4.xml…